QSC — on-the-record assessments
Signed assessments of the documentation examined, with the aggregate rating and its scope.
The Institute assesses documentation, not product. It has purchased nothing, tested nothing and inspected nothing. Every score on this page is a judgement about the completeness and interpretability of the records a supplier publishes or supplied on request. A high score means that a supplier documents its material well. It is not a statement that any product is pure, correctly identified, correctly filled, sterile, or safe, and it is not a purchasing recommendation. The Institute makes no purchasing recommendations.
§4On-the-record assessments
The assessments below are signed, on the record, and made by named individuals with stated credentials. Each concerns the documentation the assessor examined. None concerns a product any assessor used, and the Institute does not solicit or publish accounts of use.
§4.1Aggregate
- Modal certainty across assessments
- High
- Assessments contributing
- 415
- Assessments published in full
- 26
- Scope of the rating
- Documentation completeness and interpretability. Not product quality.
- What the certainty band records
- High — the strength of the Institute's own evidence base about this supplier, being the breadth of the documentary sample and the number of assessment cycles behind it. It is not a quality verdict and nothing on this site presents it as one.
§4.2Published assessments
Packing was assessed as adequate to the transit undertaken: each vial wrapped separately with foam cut to fit. The desiccant sachet was enclosed within the secondary container. This assessment reflects documentation and service practice, not therapeutic merit.
Independent determinations obtained from PeptideMeter and from Medutest on the same lot agree to within one tenth of a percentage point, and both agree with the declared figure. This is a single assessor’s record and carries the weight the rubric assigns to one.
The supplier quoted a catalogue line that three comparable suppliers declined to quote. Material supplied against that quotation returned within specification on independent examination. Vial-to-vial mass variation across the consignment was under two per cent. Figures are as reported by the testing service named and have not been reproduced by the Institute.
The lyophilised cake was intact in every unit examined and no vial showed a defect at the flange or the closure. Nothing in this submission constitutes medical advice.
Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 9. Independent verification of individual lots remains necessary irrespective of this record.
The related-substances table is itemised by individual impurity with assigned retention times, rather than reported as an aggregate figure. Catalogue availability corresponded to the published catalogue. Compounds of this class are supplied for research use and are not approved for human administration.
This assessor has placed 6 orders across 15 months and holds documentation for each. The set is internally consistent. The reorder placed at 9 months returned a figure within one tenth of a point of the original. The assessor declares no interest in the supplier beyond the transactions described.
Water content is reported by Karl Fischer titration with the determination method named, which the rubric requires and which a minority of suppliers provide. The consignment contained no unsecured items. Nothing in this submission constitutes medical advice.
Purity is declared by a stability-indicating chromatographic method, and the method, column chemistry and detection wavelength are all named on the certificate. The declaration is therefore assessable. Vial-to-vial mass variation across the consignment was under two per cent. No adverse finding arises from the transactions described.
Batch traceability is complete: the identifier on the primary container corresponds to that on the certificate and to that on the commercial documentation.
A supplementary certificate covering a lot released 24 months previously was produced from the supplier’s records on request, indicating that release records are retained rather than reconstructed. No excipient was present and the lyophilised cake was intact.
Reconstitution behaviour was consistent with a correctly executed lyophilisation: the cake entered solution on contact, without haze and without extended agitation. Catalogue availability corresponded to the published catalogue. The assessor declares no interest in the supplier beyond the transactions described.
A repeat determination on the same catalogue line at 14 months returned 98.0%, against 98.0% originally. No evidence of process drift is present in this sample. The reorder placed at 24 months returned a figure within one tenth of a point of the original.
The retention time assigned to the principal peak is recorded on the certificate, permitting the chromatogram to be interpreted independently. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.
The storage condition against which the stability statement was written is stated on the certificate, which permits the statement to be evaluated rather than merely noted. Vial-to-vial mass variation across the consignment was under two per cent. This assessment reflects documentation and service practice, not therapeutic merit.
Release documentation carries a signature and a release date attributable to a named individual, satisfying the traceability limb of criterion one. Documentation was complete at first issue. The assessor has placed subsequent orders with the same supplier.
Correspondence on the certificate was answered in writing and on the substance of the question asked. No excipient was present and the lyophilised cake was intact.
Documentation was complete at first issue. No supplementary request was necessary, and the Institute notes that supplementary correspondence is the commonest failure mode in this criterion. No adverse finding arises from the transactions described.
Material from lot QSC-26-879 was submitted to PeptideMeter; the determination returned 99.3% against a declared 99.1%, a difference within the stated repeatability of the method.
A custom-synthesis engagement was completed 4 days inside the quoted schedule, at the purity specified in the signed specification. Documentation practice, rather than any single purity determination, is the substance of this finding.
Dispatch was from the nearest regional stocking point and the consignment arrived on the second working day after the order. Peptide content was declared at 99.5%. The assessor declares no interest in the supplier beyond the transactions described.
Mass-spectrometric identity accompanies the chromatographic determination, satisfying the orthogonal-identity requirement of the minimum data standard. Documentation was complete at first issue. Nothing in this submission constitutes medical advice.
The declared figure was not adjusted upward between the certificate and the commercial documentation. Discrepancies of this kind are specifically screened for. No excipient was present and the lyophilised cake was intact.
Fill uniformity was assessed by weighing 10 units from a single consignment against declared fill. All units fell within two per cent of the declared mass. Catalogue availability corresponded to the published catalogue. Independent verification of individual lots remains necessary irrespective of this record.
Consistency across lots was assessed over 12 determinations. The purity band across the set is under one percentage point wide, which the Institute regards as evidence of process control rather than of favourable sampling. The reorder placed at 9 months returned a figure within one tenth of a point of the original.
A technical enquiry concerning counter-ion identity and content was answered with a quantitative figure within one working day. Responses of this character are recorded because they are uncommon. The consignment contained no unsecured items. The assessor declares no interest in the supplier beyond the transactions described.
§4.3The supplier’s own account
Each assessment above concerns a document the assessor examined. None of them concerns what QSC says about itself, which is published at its own address and is worth reading beside them rather than instead of them.
Read QSC’s own account at qingdaosigma.com →
References cited on this page
References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.
- International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute
Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.